Dindigul Farm Product Limited, operating under the brand **EnNutrica**, is a specialized dairy technology company transitioning from a traditional processor into India’s leading producer of **Advanced Milk Derivatives (AMD)**. The company is currently **India’s only producer of Native Milk Protein Concentrate (MPC)**, leveraging sophisticated cold-filtration technologies to serve the high-growth global nutrition and nutraceutical markets. --- ### **Technological Edge & Advanced Filtration Capabilities** EnNutrica distinguishes itself through the use of advanced membrane filtration systems sourced from global leaders such as **GE** and **Koch**. These technologies allow the company to process **99.98% farm-fresh cow milk** into high-value proteins without denaturing the molecular structure. * **Filtration Suite:** Includes **Micro-filtration, Ultra-filtration, Nano-filtration, and Reverse Osmosis (RO)**. * **Electro-Dialysis:** Utilized for advanced demineralization, essential for infant nutrition. * **Native Protein Advantage:** Unlike standard whey, the company’s **Native MPC** maintains a natural **80:20 Casein-to-Whey** ratio. This provides a dual-release energy profile (fast-acting whey and sustained-release micellar casein) that lasts **6 to 8 hours**, offering superior gut health and absorption. * **Quality Benchmarks:** Products achieve a **PDCAAS (Protein Digestibility Corrected Amino Acid Score) of 1**, the highest possible rating for protein quality. --- ### **Specialized Product Portfolio & Market Segments** The company has pivoted toward high-margin, science-backed nutritional ingredients, moving away from low-margin commodity dairy. | Product Category | Specifications & Brands | Target Applications | | :--- | :--- | :--- | | **Advanced Proteins** | **MPC (50%-85%)**, **Casein**, **Sodium Caseinate**, **WPC** | Sports nutrition, clinical nutrition, and pharmaceuticals. | | **B2B Formulations** | **Formula 7+**, **Formula 8**, **Formula 8+** | Industrial food fortification and specialized supplements. | | **Infant Nutrition** | **Demineralized Whey**, **Micro-Encapsulated Fat** | Specialized infant milk powders designed for easy digestion. | | **Retail (B2C)** | **ActivDay** (PRIME, CHOCO, Junior, Premium) | Direct-to-consumer protein powders and lifestyle nutrition. | | **Dairy Ingredients** | **SMP**, **Whole Milk Powder**, **Dairy Whitener**, **Lactose** | General food processing and B2B supply. | **New Product Development (NPD) Pipeline:** * **Lifestyle Nutrition:** "Nutrition for Women" protein powders and maternal care products. * **Convenience Dairy:** **Instant Degree Coffee** (ready-to-drink dairy whitener). * **Protein-Enriched Foods:** Development of high-protein chips, cookies, chocolates, and ice creams. --- ### **Integrated Supply Chain & Manufacturing Infrastructure** The company operates a rigorous **three-tier quality control framework** (Village level, Chilling center level, and Plant level) to ensure the purity of raw milk. * **Procurement Network:** Direct sourcing from **5,000+ farmers** across **150+ Village Level Collection Centers** in **5+ districts** of Tamilnadu. * **Strategic Partnership:** Access to a **250,000 LPD** liquid milk facility and **14 chilling centers** through **A R Dairy Food Private Limited** (Raaj Group). * **Manufacturing Base:** Located in **Dindigul, Tamilnadu**, featuring advanced tertiary-level QC labs. * **Capacity Expansion:** A new **Evaporating and Drying Plant** with a **20 Mtpd SMP capacity** is near operational. The company aims to scale total production capacity **3x by December 2025**. * **Certifications:** **FSSAI, HACCP, ISO 22000, FSSC 22000, HALAL, KOSHER,** and **EIA** approved for international trade. --- ### **Financial Performance & Capital Structure** EnNutrica recently transitioned to a public entity, listing on the **BSE SME Segment** on **June 27, 2024**. **Key Financial Metrics:** | Metric (INR Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **62.83** | **85.56** | **81.99** | | **Net Profit / (Loss) After Tax** | **(5.61)** | **8.74** | **5.17** | | **Paid-up Share Capital** | **17.98** | **17.98** | - | **Capital & Investment Highlights:** * **IPO Success:** Raised **₹34.83 Crores** by issuing **64,50,000 shares** at **₹54 per share**. * **Growth Reinvestment:** The Board has not recommended dividends for the past two fiscal years, opting to reinvest all internal accruals into capacity expansion and the **Protein segment**. * **Asset Acquisition:** Utilizing the **EPCG (Export Promotion of Capital Goods) scheme** to import high-end machinery with reduced duties to bolster export competitiveness. --- ### **Strategic Growth & Global Expansion Strategy** The company is positioning itself to capture a significant share of the **Indian Dairy Protein Market**, which is projected to grow at a **6.79% CAGR (2025–2030)**. * **Export Focus:** Aggressively targeting **ASEAN and EU** markets with **Milk Protein Concentrates**, **Edible Acid Casein**, and **Sodium Caseinate**. * **Digital Transformation:** Expanding the **ActivDay** retail brand through **e-commerce platforms** to capitalize on the digitization of the health supplement market. * **Niche Specialization:** Focusing on the **Clinical Nutrition** segment (diabetes, arthritis, and post-illness recovery) and **Infant Nutrition** to secure higher margins than traditional dairy. --- ### **Risk Profile & Governance Disclosures** Investors should note specific operational and legal risks associated with the company’s leadership and related party dependencies. * **Legal & Key Person Risk:** The Chairman and Managing Director, **Mr. Raju Rajasekaran**, was arrested in **February 2025** in connection with an investigation into **A R Dairy Food Private Limited** regarding alleged ghee adulteration (Tirumala Laddu case). He was granted **bail in July 2025**, but litigation is ongoing. * **Reputational Clarification:** The company maintains that it has no direct connection to the allegations, as it does not operate a ghee processing unit. * **Related Party Exposure:** Significant transactions occur with **A R Dairy Food Private Limited**, with shareholder-approved limits of up to **₹50 Crores** (or **10% of turnover**). * **Operational Risks:** The business is sensitive to **milk price volatility**, **weather-related supply disruptions**, and the logistical challenges of maintaining **temperature and humidity control** for high-purity protein powders.